Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 4/20 | 0.69 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.69 |
| ▸ | PTGS2 | P35354 | 12/20 | 0.57 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.47 |
| ▸ | JAK2 | O60674 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | HTR7 | P34969 | 1/20 | 0.46 |
| ▸ | HTR6 | P50406 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18552201 | 1.00 | ESR1 (0.69) | ESR1ESR2PTGS2MAPK14JAK2 | |
| SCHEMBL12781577 | 0.91 | ESR1 (0.57) | ESR1ESR2PTGS2MAPK14HTR7 | |
| SCHEMBL12781572 | 0.91 | ESR1 (0.57) | ESR1ESR2PTGS2MAPK14HTR7 | |
| SCHEMBL13461181 | 0.86 | ESR1 (0.92) | ESR1ESR2PTGS2MAPK14HTR6 | |
| SCHEMBL22649305 | 0.86 | ESR1 (0.92) | ESR1ESR2PTGS2MAPK14HTR6 | |
| SCHEMBL18610257 | 0.84 | ESR1 (0.73) | ESR1ESR2PTGS2MAPK14 | |
| SCHEMBL27902506 | 0.84 | ESR1 (0.67) | ESR1ESR2PTGS2MAPK14 | |
| SCHEMBL7040942 | 0.82 | PTGS2 (0.72) | ESR1ESR2PTGS2MAPK14 | |
| SCHEMBL7041577 | 0.82 | ESR1 (0.73) | ESR1ESR2PTGS2 | |
| SCHEMBL15563263 | 0.82 | PTGS2 (0.72) | ESR1ESR2PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11177443-B2 | Compound and light emitting diode including same | LMS CO., LTD (KR) | 2021-11-16 | — | — | US | disclosed |
| WO-2017030424-A1 | NOVEL COMPOUND AND LIGHT EMITTING DIODE INCLUDING SAME | 주식회사 엘엠에스 | 2017-02-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11177443-B2 | Compound and light emitting diode including same | ARL1, ALDH1A2, DRD1 | ESR1 26/4885ESR2 39/4885PTGS2 1976/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.